Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China's State Council Announces Healthcare Reform Policies

publication date: May 18, 2015
China will scrap the 15% mark-up on drug sales in hospital pharmacies, a long-planned move that was announced by China's State Council on Sunday. The mark-up will initially end in 100 large-city hospitals, and then be extended throughout all of China in 2017. In addition, the Council said insurance payments will be based on the disease being treated rather than the number or type of services rendered. And provincial/local governments were asked to distribute healthcare resources "optimally," steering patients away from the overcrowded big city hospitals with the best reputations. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital